Meeting on IV drug container labels
FDA is holding a public meeting Jan. 11, 2007 to discuss enhancing container labeling for intravenous drug products. Label design issues to be discussed include placement, style and type of information; the need for standard expression of strength; quantity of information; and use of color. The public meeting will be held from 8 a.m. to 4 p.m. at Lister Hill Center Auditorium in Bethesda, MD...
You may also be interested in...
The US FDA and NIST have agreed to help industry modernize and update pharmaceutical manufacturing methods and to improve supply chain resilience.
Medtronic is sponsoring a trial to evaluate its adaptive deep brain stimulation technology, a unique feature of the Percept PC device for treating Parkinson’s disease.
The company cited lackluster efficacy in its decision to discontinue development of V590 and V591. It will instead develop two drugs to treat COVID-19.